• Home
  • NEW DAY MEDICINE
  • 2(40)2022
  • 56 -2 (40) 2022 — Urokov Sh.T., Babanazarov U.T., — PECULIARITIES OF THE STATE OF THE LIVER IN PATIENTS WITH POST-COVID-19

56 -2 (40) 2022 — Urokov Sh.T., Babanazarov U.T., — PECULIARITIES OF THE STATE OF THE LIVER IN PATIENTS WITH POST-COVID-19

PECULIARITIES OF THE STATE OF THE LIVER IN PATIENTS WITH POST-COVID-19

Urokov Sh.T., Bukhara State Medical Institute

Babanazarov U.T., Bukhara State Medical Institute

Eshonov O.Sh. Bukhara State Medical Institute

Resume

It is known that coronavirus infection COVID-19 occurs with multiple organ damage to the body. The review article reveals the mechanisms of liver damage in COVID-19 coronavirus infection, the impact of chronic liver diseases on the course and prognosis of COVID-19 disease. The conducted studies on the study of liver damage in COVID-19 are summarized.

Key words: COVID-19, chronic liver disease, novel coronavirus disease, liver damage.

First page

298

Last page

301

For citation: Urokov Sh.T., Babanazarov U.T., Eshonov O.Sh. PECULIARITIES OF THE STATE OF THE LIVER IN PATIENTS WITH POST-COVID-19 //New Day in Medicine 2(40)2022 298-301 https://cutt.ly/zAFkdPw

LIST OF REFERENCES:

  1. Ильченко Л.Ю., Никитин И.Г., Федоров И.Г. COVID-19 и поражение печени. Архивъ внутренней медицины. 2020; 10(3): 188-197. DOI: 10.20514/2226-6704-2020-10-3-188-197.
  2. Иноятов А.Ш. и др. Оценка состояния беременных женщин с диабетом, при заражении COVID-19 //Новый день в медицине. – 2020. – №. 2.С. 101-103.
  3. Маннанова И.В., Понежева Ж.Б., Макашова В. В. и др.   2020. Некоторые аспекты повреждения печени при инфекции, вызванной SARS-COV-2. COVID-19 preprints.microbe.ru. Временные методические рекомендации: профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 8.1 (01.10.2020).
  4. Мусаева Д. М., Раджабов Н.Г. Перспективы изучения применения препарата кверцетина для профилактики COVID-19 у медицинских работников. – 2020.
  5. Мусаева Д.М., Очилов А.К., Очилова Г.С. Коррекция фармакометаболизирующей функции печени антиоксидантами // Достижения науки и образования. 2018. №10 (32).
  6. Никитин И.Г., Ильченко Л.Ю, Федоров ИГ, Тотолян ГГ. Поражение печени при COVID-19: два клинических наблюдения. Альманах клинической медицины. 2020;48(6):412–21. doi: 10.18786/2072-0505-2020-48-053.
  7. Oblokulov A.R., Niyozov G.E. Clinical and epidemiological characteristics of patients with COVID-19 (2020) International Journal of Pharmaceutical Research, 12 (4), pp. 3749-3752.
  8. Obidov U.O. Minimally invasive interventions in the treatment of patients with mechanical jaundice. Europe’s Journal of Psychology 2021. Vol. 17(3), 34-40.
  9. Рейзис А.Р., Понежева Ж.Б., Макашова В.В., Омарова Х.Г., Маннанова И.В., Горелов А.В. 2020. Хронические заболевания печени в период пандемии COVID – 19. COVID19-preprints.microbe.ru.
  10. Рейзис А. Р., Понежева Ж. Б., Макашова В. В. и др. 2020. Поражение печени при COVID-19. Covid19-preprints.microbe.RU.
  11. Bertolini A., van de Peppel IP, Bodewes FAJA, et al. Abnormal liver function tests in COVID-19 patients: relevance and potential pathogenesis [published online ahead of print, 2020 Jul 23]. Hepatology. 2020;10.1002/hep.31480. doi:10.1002/hep.31480
  12. Bhimraj A., Morgan R.L., Shumaker A.H., Lavergne V., Baden L., Cheng V.C., Edwards K.M., Gandhi R., Muller W.J., O’Horo J.C., Shoham S., Murad M.H., Mustafa R.A., Sultan S., Falck-Ytter Y. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2020:ciaa478.
  13. Chen N., Zhou N., Dong X. et al. Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet. 2020;395(10223):507-13.
  14. Cai Q., Huang D., Yu H., et al. COVID-19: Abnormal liver function tests. J Hepatol 2020. Apr 13. doi:10.1016/j.jhep.2020.04.0066.
  15. Guan W.J., Ni Z.Y., Hu Y. et al. China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in  China. N Engl J Med. 2020;382(18): 1708–20.
  16. Portincasa P, Krawczyk M, Machill A. et al. Hepatic consequences of COVID-19 infection. Lapping or biting?. Eur J Intern Med. 2020;77:18-24. doi:10.1016/j.ejim.2020.05.035.
  17. Sorbello M., El-Boghdadly K., Di Giacinto I. et al. Societa Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI) Airway Research Group, and The European Airway Management Society. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice. Anaesthesia. 2020;75(6): 724–32. doi: 10.1111/anae.15049
  18. Sun J., Aghemo A., Forner A., Valenti L. COVID-19 and liver disease. Liver Int 2020 Apr. 6. doi:10.1111/liv.14470
  19. Tapper E.B., Asrani S.K. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care. J Hepatol. 2020;73(2): 441–5.
  20. Xu L., Liu J., Lu M. et al. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40(5):998-1004. doi: 10.1111/liv.14435.

file

download